NPY2R and familial pancreatic carcinoma: NPY2R is often strongly expressed in neuroblastomas, paragangliomas, and renal carcinomas [22], and NPY2R agonists such as BIM-43004-1 suppress the growth of human pancreatic cancer xenografts in mice [23].